Mammalian cell toxicity and candidacidal mechanism of Arg- or Lys-containing Trp-rich model antimicrobial peptides and their d-enantiomeric peptides

[1]  J. Bang,et al.  Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity , 2009, Peptides.

[2]  Kyung-Soo Hahm,et al.  Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides. , 2009, Biochimica et biophysica acta.

[3]  A. Mochon,et al.  The Antimicrobial Peptide Histatin-5 Causes a Spatially Restricted Disruption on the Candida albicans Surface, Allowing Rapid Entry of the Peptide into the Cytoplasm , 2008, PLoS pathogens.

[4]  H. Vogler,et al.  Tobacco mosaic virus Movement Protein Enhances the Spread of RNA Silencing , 2008, PLoS pathogens.

[5]  M. Benincasa,et al.  Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. , 2006, The Journal of antimicrobial chemotherapy.

[6]  Y. Shai,et al.  Ultrashort antibacterial and antifungal lipopeptides , 2006, Proceedings of the National Academy of Sciences.

[7]  H. Vogel,et al.  Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. , 2006, Biochimica et biophysica acta.

[8]  M. Edgerton,et al.  Candida albicans Cell Wall Ssa Proteins Bind and Facilitate Import of Salivary Histatin 5 Required for Toxicity* , 2006, Journal of Biological Chemistry.

[9]  Sunkyu Kim,et al.  Correlation between the activities of α-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times , 2005, Peptides.

[10]  Laszlo Otvos,et al.  Antibacterial peptides and proteins with multiple cellular targets , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[11]  K. Hahm,et al.  Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. , 2005, Biochemistry.

[12]  M. Andrés,et al.  Different Anti-Candida Activities of Two Human Lactoferrin-Derived Peptides, Lfpep and Kaliocin-1 , 2005, Antimicrobial Agents and Chemotherapy.

[13]  Shunzi Li,et al.  Individual substitution analogs of Mel(12–26), melittin's C‐terminal 15‐residue peptide: their antimicrobial and hemolytic actions , 2003, FEBS letters.

[14]  Niv Papo,et al.  Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? , 2003, Peptides.

[15]  H. Vogel,et al.  Conformation of a Bactericidal Domain of Puroindoline a: Structure and Mechanism of Action of a 13-Residue Antimicrobial Peptide , 2003, Journal of bacteriology.

[16]  Niv Papo,et al.  Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides. , 2003, Biochemistry.

[17]  P. Kinnunen,et al.  Binding of the Antimicrobial Peptide Temporin L to Liposomes Assessed by Trp Fluorescence* , 2002, The Journal of Biological Chemistry.

[18]  Y. Shai,et al.  Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. , 2002, Biochemistry.

[19]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[20]  Y. Shai,et al.  From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides , 2001, Peptides.

[21]  R. Hancock,et al.  Structure and Mechanism of Action of an Indolicidin Peptide Derivative with Improved Activity against Gram-positive Bacteria* , 2001, The Journal of Biological Chemistry.

[22]  J. Killian,et al.  How proteins adapt to a membrane-water interface. , 2000, Trends in biochemical sciences.

[23]  C. B. Park,et al.  Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Vogel,et al.  Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.

[25]  S. White,et al.  The preference of tryptophan for membrane interfaces. , 1998, Biochemistry.

[26]  Jiang Hong,et al.  A Repertoire of Novel Antibacterial Diastereomeric Peptides with Selective Cytolytic Activity* , 1997, The Journal of Biological Chemistry.

[27]  E. Krause,et al.  Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. , 1997, Biochemistry.

[28]  S. Lee,et al.  Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes. , 1996, Biochemistry.

[29]  J. Killian,et al.  Induction of nonbilayer structures in diacylphosphatidylcholine model membranes by transmembrane alpha-helical peptides: importance of hydrophobic mismatch and proposed role of tryptophans. , 1996, Biochemistry.

[30]  D. McCarthy,et al.  Comparison of the effects of hydrophobicity, amphiphilicity, and α‐helicity on the activities of antimicrobial peptides , 1995, Proteins.

[31]  A. Mason,et al.  Oral Candida: Clearance, Colonization, or Candidiasis? , 1995, Journal of dental research.

[32]  Wayne L. Smith,et al.  Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. , 1992, The Journal of biological chemistry.

[33]  Y. Shai,et al.  Channel formation properties of synthetic pardaxin and analogues. , 1990, The Journal of biological chemistry.

[34]  B. de Kruijff,et al.  The role of charge and hydrophobicity in peptide-lipid interaction: a comparative study based on tryptophan fluorescence measurements combined with the use of aqueous and hydrophobic quenchers. , 1990, Biochemistry.

[35]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[36]  B. Roelofsen,et al.  The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. , 1973, Biochimica et biophysica acta.

[37]  G. R. Bartlett.  Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[38]  Khyati Kapoor,et al.  Multidrug resistance in yeast Candida. , 2005, International review of cytology.

[39]  A. Waring,et al.  Direct comparison of membrane interactions of model peptides composed of only Leu and Lys residues , 2003, Biopolymers.

[40]  H. Vogel,et al.  Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[41]  H. G. Boman,et al.  Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.

[42]  F. Odds,et al.  Candida infections: an overview. , 1987, Critical reviews in microbiology.